Urethral Cancer Clinical Trials in Georgia

Georgia's Online Cancer Information Center


back

Urethral Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Urethral Cancer
Cancer Type = Urethral Cancer
NCI ID Cancer Type Trial Name
There are currently 5 active Urethral Cancer clinical trials in Georgia.
NCI ID Cancer Type Trial Name
1.
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Cancer Type
Anal Cancer, Bladder Cancer, Cervical Cancer, Esophogeal Cancer, Lung Cancer, Penile Cancer, Urethral Cancer
NCT ID
NCT07217171
Protocol IDs
EIU-104101
Drug: EVOLVE104
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
2.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Cancer Type
Bladder Cancer, Kidney Cancer, Unknown Primary, Ureter Cancer, Urethral Cancer
NCT ID
NCT04879329
Protocol IDs
RC48G001
NCI-2022-03375
2022-500030-28
2022-500030-28-01
C5731002
KEYNOTE-D78
MK-3475-D78
RC48 G001
3.
NCORP Trial
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Cancer Type
Urethral Cancer
NCT ID
NCT07129993
Protocol IDs
DS1062-328
Treatment Sites (7)
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
Piedmont Cancer Institute - Atlanta
Atlanta
Katie Adams
678-298-3238
Piedmont Cancer Institute - Fayetteville
Fayetteville
678-298-3238
Piedmont Cancer Institute – Locust Grove
Locust Grove
Piedmont Cancer Institute - Newnan
Newnan
Katie Adams
678-298-3238
Piedmont Cancer Institute – Sandy Springs
Atlanta
Piedmont Cancer Institute - Stockbridge
Stockbridge
Katie Adams
678-298-3238
4.
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
Cancer Type
Bladder Cancer, Kidney Cancer, Unknown Primary, Ureter Cancer, Urethral Cancer
NCT ID
NCT06632951
Protocol IDs
M25-204
NCI-2024-10299
2024-515506-11-00
Treatment Sites (1)
City of Hope Atlanta
Newnan
Brian Wortz, PharmD, ACRP-CP
770-400-6169
5.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Cancer Type
Bladder Cancer, Kidney Cancer, Penile Cancer, Urethral Cancer
NCT ID
NCT03866382
Protocol IDs
A031702
A031702
NCI-2019-01266
Treatment Sites (4)
Emory Johns Creek Hospital
Johns Creek
Emory Saint Joseph's Hospital
Atlanta
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Find Cancer Care

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

 

Georgia CORE reduces the burden of cancer in our state through research, education, and advocacy.